Physician profile
Jed T Poll
NPI 1376656124
$1,080.16
in general payments reported to CMS, 2019-2025
18 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $115 · 2021: $50.56 · 2022: $195 · 2023: $73.61 · 2024: $300 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $220.48 | 2023-2025 | Xiidra, Stellaris, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $157.53 | 2020-2025 | |
| Alcon Vision LLC | $113.37 | 2019-2025 | Luxor, Clareon Panoptix Pro |
| Novartis Pharmaceuticals Corporation | $84.54 | 2019-2021 | |
| Abbvie INC. | $81.50 | 2022-2024 | |
| Allergan, INC. | $72.02 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $65.00 | 2019-2025 | Eylea Hd |
| New World Medical,INC. | $45.16 | 2024 | Clearpath, Streamline, Kahook Dual Blade |
| Astellas Pharma US INC | $43.22 | 2025 | Izervay |
| Rxsight INC | $37.51 | 2022 | |
| Apellis Pharmaceuticals, INC. | $33.02 | 2023-2025 | Syfovre |
| Glaukos Corporation | $27.67 | 2023-2024 | Idose |
| Oyster Point Pharma, INC. | $25.46 | 2024 | Tyrvaya |
| Amgen INC. | $25.43 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $18.89 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.62 | 2021 | |
| Genentech, INC. | $11.09 | 2020 | |
| Abb Con-Cise Optical Group LLC | $6.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Poll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.